Health
CN Bio partners with Imperial College London to uncover therapeutic targets for alcoholic hepatitis – News-Medical.net
CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems to improve the accuracy and efficiency of drug discovery, today announced a collaboration with Imperial College London, a world-class research univer…
CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with Imperial College London, a world-class research university. The research will harness CN Bio’s Liver-on-Chip technology to advance the understanding of the underlying mechanisms of alcoholic hepatitis and uncover novel targets for drug discovery and development.
Despite being an increasin…
-
Noosa News17 hours agoRaising your voice | Noosa Today
-
Noosa News8 hours agoNRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs
-
Noosa News14 hours agoMitch Power Quick Shear event gets men talking about mental health
-
General16 hours agoThailand punches above its weight in film creativity and cross-border appeal. Here’s why